Skip to main content

Table 2 Causes of ART discontinuation between the 2 groups

From: Safety and efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine antiretroviral therapy between HIV-infected patients with baseline CD4 <50 versus CD4 ≥ 50 cells/mm3

Causes of discontinuation

Group A (n = 120)

Group B (n = 84)

P value

NVP-associated skin rashes grade II, III and IV

11 (9.2%)

12 (14.3%)

0.269

Virological failure

9 (7.5%)

2 (2.4%)

0.129

Lost to follow-up

7 (5.8%)

5 (6.0%)

1.000

Died

4 (3.3%)

1 (1.2%)

0.651

Referred to other hospitals

1 (0.8%)

0*

1.000

d4T-associated lactic acidosis

1 (0.8%)

1 (1.2%)

1.000

  1. * Substitute 0 as 1 to calculate P value